Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lactiplantibacillus Plantarum PD01 Supplementation Reduces Microplastics and Microplastic-associated Chemicals in Humans
Sponsor: Fudan University
Summary
The study attempts to conduct randomized double-blind controlled trials to understand whether daily exposure to microplastics (MPs) can cause potential impacts on human health, explore whether the intake of Lactiplantibacillus plantarum PD01 can alleviate potential obesity-related damages caused by MPs, and provide a scientific basis for the prevention and nutritional intervention of health hazards caused by MP exposure.
Official title: Lactiplantibacillus Plantarum PD01 Supplementation Reduces Microplastics and Microplastic-associated Chemicals in Humans: A Randomized, Double-blind, Placebo-controlled Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
96
Start Date
2025-11-30
Completion Date
2026-02-10
Last Updated
2026-08-17
Healthy Volunteers
Yes
Interventions
Probiotics (Lactiplantibacillus plantarum PD01)
The probiotic supplement includes 0.2g Lactiplantibacillus plantarum FABYIO PD01 (containing 10 billion CFU) and 1.8g Fructooligosaccharides.
Placebo
The placebo includes 2.0g Fructooligosaccharides with an indistinguishable appearance and texture.
Locations (1)
School of Public Health, Fudan University
Shanghai, Xuhui, China